Quantcast

Our website use cookies to improve and personalize your experience and to display advertisements(if any). Our website may also include cookies from third parties like Google Adsense, Google Analytics, Youtube. By using the website, you consent to the use of cookies. We have updated our Privacy Policy. Please click on the button to check our Privacy Policy.

Your information is NEVER sold to a third party. 

Internet Villain Martin Shrkeli is planning to hike the price of another drug

Advertisements
Share On Social Media
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  

MARTIN1SAO PAOLO — There’s trouble in the world of pharmaceuticals once again, and this time, well, they’re all accounted back to none other than Martin Shrkeli. According to the New York Times,  Shrkeli has reportedly purchased rights to a premier drug in Latin America used to treat the often fatal disease known as Chagas.

The disease, hasn’t widely been seen in Northern America since 1955. However, in Latin America the disease is rather prominent and the drug is beneficial to most. As of now, the drug ranges about $50-$100 to retrieve it, however, Shrkeli reportedly plans to raise the praise to nearly $60,000-$100,000.

So what’s the master plan? As Reuters uncovered, governments give companies making drugs that specifically treat “parasatic diseases” vouchers. These vouchers can later be sold for up to $350m.


Share On Social Media
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
See also  The Daily News has a message in response to #Orlando
By SHK

Sultan H. Khane II is the Editor-in-Chief of Bazaar Daily News and its 5 sister properties.

Leave a Reply

Related Posts

Developing: The U.S CDC is expected to re-recommend the use of face masks for vaccinated people as the Delta variant of COVID-19 has taken hold in America.

X
No widgets found. Go to Widget page and add the widget in Offcanvas Sidebar Widget Area.
Skip to content